Related Experiment Videos
[Viral vectors for clinical gene therapy]
John-Erik Stig Hansen1, Gregers J Gram
1Center for Små Handicapgrupper, og H:S Hvidovre Hospital, infektionsmedicinsk afdeling. jesh@dadlnet.dk
Ugeskrift for Laeger
|October 5, 2002
Summary
Gene therapy shows promise for inherited and acquired diseases, with early clinical trials yielding positive results. Challenges remain, particularly with viral vectors, but advancements offer new therapeutic potential.
Area of Science:
- Biomedical research
- Molecular biology
- Genetics
Context:
- Clinical trials in gene therapy are emerging with initial positive outcomes.
- Numerous trials have faced challenges, highlighting areas for improvement.
- Viral vectors represent a significant hurdle in gene transfer efficacy.
Purpose:
- To analyze early clinical results of gene therapy trials.
- To identify key challenges and opportunities for future development in gene therapy.
- To assess the therapeutic potential of gene therapy for various diseases.
Summary:
- The first positive clinical results from gene therapy trials are now apparent.
- Successful trials often involve monogenetic diseases treated ex vivo with retroviral vectors.
- Gene therapy demonstrates potential for rare inherited and acquired conditions like ischemic heart disease.
Impact:
- Identifies critical issues in viral vector technology for gene transfer.
- Highlights the therapeutic promise of gene therapy for specific genetic and acquired diseases.
- Provides insights for advancing gene therapy research and clinical applications.